scholarly journals Characterization of Novel Lactobacillus paracasei HY7017 Capable of Improving Physiological Properties and Immune Enhancing Effects Using Red Ginseng Extract

Fermentation ◽  
2021 ◽  
Vol 7 (4) ◽  
pp. 238
Author(s):  
Sung-Joon Mo ◽  
Bora Nam ◽  
Chu-Hyun Bae ◽  
Soo-Dong Park ◽  
Jae-Jung Shim ◽  
...  

Red ginseng has powerful potential for use as a prebiotic, but its use is limited due to its antibacterial activity. The aim of this study is to present panax ginseng’s endophytic lactic acid bacteria capable to overcome the antibacterial activity of red ginseng and improve their characteristic. Lactobacillus paracasei HY7017 (HY7017) was cultured in a medium supplemented with red ginseng. The probiotic properties and immune-enhancing effects of HY7017 were investigated in vitro and in vivo. HY7017 was proliferated strongly in RGE and had significantly improved properties compared with an L. paracasei type strain ATCC25302. HY7017 cultured in RGE-supplemented medium increased the production of nitric oxide, TNF-α, and IL-6 in macrophages, and increased IL-12 and IFN-γ secretion in splenocytes. Furthermore, HY7017 restored WBC counts, increased the amount of IL-2 and IFN-γ released, and enhanced the cytotoxicity of natural killer cells when orally administered to immunosuppressed mice. Moreover, HY7017 has properties that make it suitable as a probiotic, such as stability in the gastrointestinal tract and adhesion to Caco-2 cells. This study showed that HY7017 cultured with RGE may contribute to the development of probiotics to enhance immunity.

2004 ◽  
Vol 11 (2) ◽  
pp. 266-271 ◽  
Author(s):  
Guénolée Prioult ◽  
Sophie Pecquet ◽  
Ismail Fliss

ABSTRACT We have previously demonstrated that Lactobacillus paracasei NCC2461 may help to prevent cow's milk allergy in mice by inducing oral tolerance to β-lactoglobulin (BLG). To investigate the mechanisms involved in this beneficial effect, we examined the possibility that L. paracasei induces tolerance by hydrolyzing BLG-derived peptides and liberating peptides that stimulate interleukin-10 (IL-10) production. L. paracasei peptidases have been shown to hydrolyze tryptic-chymotryptic peptides from BLG, releasing numerous small peptides with immunomodulating properties. We have now shown that acidic tryptic-chymotryptic peptides stimulate splenocyte proliferation and gamma interferon (IFN-γ) production in vitro. Hydrolysis of these peptides with L. paracasei peptidases repressed the lymphocyte stimulation, up-regulated IL-10 production, and down-regulated IFN-γ and IL-4 secretion. L. paracasei NCC2461 may therefore induce oral tolerance to BLG in vivo by degrading acidic peptides and releasing immunomodulatory peptides stimulating regulatory T cells, which function as major immunosuppressive agents by secreting IL-10.


2017 ◽  
Vol 21 (2) ◽  
pp. 56-62 ◽  
Author(s):  
Chan-Sik Kim ◽  
Kyuhyung Jo ◽  
Mi-Kyung Pyo ◽  
Jin Sook Kim ◽  
Junghyun Kim

2004 ◽  
Author(s):  
Πέτρος-Αχιλλέας Μαραγκουδάκης
Keyword(s):  
E Coli ◽  
Tnf Α ◽  

Σκοπός: Ο σκοπός της παρούσας διατριβής ήταν η εξέταση του προβιοτικού δυναμικού στελεχών οξυγαλακτικών βακτηρίων μέσω μίας σειράς in vitro δοκιμών, και της μετέπειτα εφαρμογής επιλεγμένων στελεχών σε in vivo μοντέλα ποντικών έναντι της λοίμωξης του Η. pylori και της ελκώδους κολίτιδας, αλλά και σε τεχνολογικό επίπεδο στην παρασκευή γιαουρτιού.Υλικά και μέθοδοι: Στη διατριβή αυτή μελετήθηκαν 51 στελέχη Lactobacillus του Εργαστηρίου Γαλακτοκομίας του Γεωπονικού Πανεπιστημίου Αθηνών, απομονωμένα κυρίως από γαλακτοκομικά προϊόντα και κόπρανα προβάτων, καθώς και 22 στελέχη Enterococcus και Streptococcus, απομονωμένα από κόπρανα προβάτων. Τα στελέχη αυτά εξετάστηκαν σε μία σειρά in vitro δοκιμών που αφορούν την επιβίωσή τους σε συνθήκες εξομοίωσης του ανθρώπινου γαστρεντερικού συστήματος, οι οποίες περιελάμβαναν επιβίωση σε χαμηλό pH, επιβίωση παρουσία των πρωτεολυτικών ενζύμων πεψίνη και παγκρεατίνη, και επιβίωση παρουσία χολικών αλάτων.Στην συνέχεια τα στελέχη εξετάστηκαν σε δοκιμές βασικές για την ασφάλεια χρήσης τους στον ανθρώπινο οργανισμό. "Ολα τα στελέχη δοκιμάστηκαν ως προς την αιμολυτική τους δραστικότητα, και τα στελέχη γαλακτοβακίλλων συγκεκριμένα για την ανθεκτικότητά τους έναντι επιλεγμένων αντιβιοτικών.Παράλληλα, εξετάστηκαν in vitro βασικές ιδιότητες που θεωρούνται επιθυμητές για τα προβιοτικά στελέχη, όπως υδρόλυση των χολικών αλάτων, μελέτη της υδροφοβίας και της ικανότητας πρόσδεσης των γαλακτοβακίλλων σε κύτταρα Caco-2, ικανότητά διέγερσης κυττάρων του ανθρώπινου οργανισμού (PBMCs), καθώς και μελέτη της αντιμικροβιακής δράσης έναντι παθογόνων βακτηρίων και της δυνατότητάς αναστολής της πρόσδεσης παθογόνων σε κύτταρα Caco-2.Στην συνέχεια πραγματοποιήθηκαν in vivo μελέτες σε ποντίκια, για την εξακρίβωση του προβιοτικού χαρακτήρα επιλεγμένων στελεχών. Τα στελέχη L. casei Shirota ACA-DC 6002 και L. paracasei subsp. tolerans ACA-DC 4037 χορηγήθηκαν σε ποντίκια επιμολυσμένα με Η. pylori και αξιολογήθηκε η επίδραση των γαλακτοβακίλλων αυτών στον αποικισμό του παθογόνου και στην αξιολόγηση του βαθμού και της δραστικότητας στο στομάχι. Επίσης, τα στελέχη αυτά χρησιμοποιήθηκαν και για την πρόληψη TNBS- κολίτιδας σε ποντίκια.Τέλος, επιλεγμένα στελέχη γαλακτοβακίλλων αξιολογήθηκαν για την τεχνολογική τους εφαρμογή, μελετώντας την ικανότητά οξίνϊσης του γάλακτος και τη χρήση τους ως καλλιέργειες για την παρασκευή γιαούρτηςΑποτελέσματα: Ορισμένα στελέχη βρέθηκαν να έχουν ικανοποιητική επιβίωση σε συνθήκες εξομοίωσης του ανθρώπινου πεπτικού συστήματος. Κανένα στέλεχος δεν βρέθηκε να έχει ισχυρή (β-) αιμολυτική δράση, ενώ η αντοχή των γαλακτοβακίλλων έναντι επιλεγμένων αντιβιοτικών δεν παρουσιάστηκε διαφορετική από την έμφυτη και αναμενόμενη, ανάλογα το είδος των εξεταζόμενων γαλακτοβακίλλων, ενώ αρκετά στελέχη παρουσίασαν ικανότητα υδρόλυσης χολικών αλάτων. Τα στελέχη παρουσίασαν ποικιλόμορφη πρόσδεση στους οργανικούς διαλύτες, αλλά γενικά τα περισσότερα στελέχη δεν παρουσίασαν μεγάλη υδροφοβία, ενώ αρκετά στελέχη γαλακτοβακίλλων παρουσίασαν ικανοποιητική πρόσδεση σε κύτταρα Caco-2 (>5%), με το στέλεχος L. plantarum ACA-DC 146 (25% πρόσδεση) να ξεχωρίζει. Το ίδιο στέλεχος, μαζί με το L. paracasei subsp. tolerans ACA-DC 4037 βρέθηκαν να προκαλούν την έκκριση υψηλών επιπέδων φλεγμονωδών κυτταροκινών (IL-12, TNF-α και IFN-γ) από PBMCs, ενώ αντίθετα το στέλεχος L. casei Shirota ACA-DC 6002 προκάλεσε την έκκριση της αντιφλεγμονώδους κυτταροκίνης IL-10. Παρόλο που κανένα από τα υπερκείμενα των στελεχών δεν παρεμπόδισε τα στελέχη E. coli, S. typhimurium και Η. pylori, ορισμένα στελέχη, όπως τα L. casei Shirota, L. plantarum ACA-DC 146 και L. paracasei subsp. tolerans ACA-DC 4037 προκάλεσαν την αναστολή της πρόσδεσης εντερικών παθογόνων (E. coli και S. typhimurium) σε κύτταρα Caco-2 σε επίπεδα μέχρι και 50%.In vivo, η χορήγηση του L. casei Shirota ACA-DC 6002 σε ποντίκια οδήγησε στην μείωση του βαθμού και της δραστικότητας της γαστρίτιδας αλλά και στον αποικισμό του Η. pylori. Παρόμοια αποτελέσματα, αλλά σε μικρότερη έκταση, παρατηρήθηκαν με την χορήγηση του στελέχους L. paracasei subsp. tolerans ACA-DC 4037. Παράλληλα, το στέλεχος L. casei Shirota ACA-DC 6002 δείχνει να παρέχει προστασία σε ποντίκια κατά την πρόκληση ελκώδους κολίτιδας με την χορήγηση TNBS.Σε τεχνολογικό επίπεδο, κανένα από τα εξεταζόμενα στελέχη δεν παρουσίασε υψηλή ικανότητα οξύνισης στο γάλα και κατά συνέπεια δεν ήταν δυνατόν να χρησιμοποιηθούν ως εναρκτήριες καλλιέργειες για την παρασκευή γιαούρτης. Από την άλλη, καθώς κανένα στέλεχος δεν παρεμποδίζει αλλά και δεν παρεμποδίζεται από τις παραδοσιακές εναρκτήριες καλλιέργειες γιαούρτης, ήταν δυνατή η χρήση τους ως συμπληρωματικές καλλιέργειας για την παρασκευή γιαούρτης. Στην συνέχεια επιλεγμένα στελέχη χρησιμοποιήθηκαν για το σκοπό αυτό και το στέλεχος L. paracasei subsp. tolerans ACA- DC 4037 ξεχώρισε όταν χρησιμοποιήθηκε ως συμπληρωματική καλλιέργεια για την παρασκευή γιαούρτης με εμβόλιο πηγμένου γάλακτος (1% ν/ν) στους 42°C, λόγω της υψηλής μικροβιακής, φυσικοχημικής και οργανοληπτικής ποιότητας του προϊόντος. Συμπεράσματα: Τα στελέχη L. casei Shirota ACA-DC 6002, L. plantarum ACA-DC 146 και L. paracasei subsp. tolerans ACA-DC 4037, επέδειξαν υποσχόμενο προβιοτικό δυναμικό κατά την διάρκεια εκτεταμένων in vitro και in vivo δοκιμών. Η μελέτη αυτή επιβεβαιώνει τις προβιοτικές ιδιότητες του L. casei Shirota και επιδεικνύει την πιθανή εφαρμογής του στη λοίμωξη του Η. pylori και στην ελκώδη κολίτιδα στον άνθρωπο. Επιπλέον, το στέλεχος L paracasei subsp. tolerans ACA-DC 4037 διαθέτει επίσης δυναμικό χρήσης έναντι του Η. pylori αλλά και στην παρασκευή ενός επιτυχημένου προβιοτικού γιαουρτιού. Τέλος, το στέλεχος L. plantarum ACA-DC 146 μπορεί να εξεταστεί in vivo σε μοντέλα αλλεργικών αντιδράσεων, λόγω της υψηλής αντιφλεγμονώδους επίδρασής τους σε ανθρώπινα περιφερειακά μονοπύρηνα (PBMCs.)


2021 ◽  
Vol 2021 ◽  
pp. 1-14
Author(s):  
Chong Li ◽  
Yongpeng He ◽  
Yue Yang ◽  
Yuting Gou ◽  
Shuting Li ◽  
...  

This study is aimed at identifying the bioactive components in lotus leaf flavonoid extract (LLFE) and analyzing the antioxidant and anti-inflammatory activities of LLFE in vitro and in vivo. The flavonoids in LLFE were determined by UHPLC-MS/MS. The effect of LLFE on damaged 293T cells (H2O2, 0.3 mmol/L) was determined by MTT assay, and the activity of antioxidant enzymes was measured by kits. We studied the antioxidant and anti-inflammatory effects of LLFE on D-Gal/LPS (30 mg/kg·bw and 3 μg/kg·bw)-induced aging mice. We also evaluated the main organ index, pathological changes in the liver, lung, and kidney, liver function index, biochemical index, cytokine level, and mRNA expression level in serum and liver. The results showed that LLFE contains baicalein, kaempferol, kaempferid, quercetin, isorhamnetin, hyperoside, lespenephryl, and rutin. LLFE reduced the oxidative damage sustained by 293T cells, increased the levels of SOD, CAT, GSH, and GSH-Px, and decreased the level of MDA. The animal studies revealed that LLFE reduced oxidative damage and inflammation in injured mice, inhibited increases in AST, ALT, MDA, and NO, increased SOD, CAT, GSH, and GSH-Px levels, upregulated anti-inflammatory cytokines IL-10 and IL-12, and downregulated proinflammatory cytokines IL-6, IL-1β, TNF-α, and IFN-γ. Furthermore, the expression of antioxidant- and anti-inflammatory-related mRNA was consistent with the above results.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 1311-1311
Author(s):  
Corinna Leng ◽  
Cuiling Li ◽  
Judy Ziegler ◽  
Anna Lokshin ◽  
Suzanne Lentzsch ◽  
...  

Abstract Histone deacetylase (HDAC) inhibitors have been shown to reduce development of graft versus host disease [GVHD] following allogeneic bone marrow transplantation [BMT]. Administration of the HDAC inhibitor suberonylanilide hydroxamic acid [SAHA] resulted in a significantly reduced GVHD-dependent mortality following fully MHC-mismatched allogeneic BMT. Median Survival Time (MST) for vehicle and SAHA-treated mice were 7.5 days and 38 days respectively. However, SAHA treatment did not affect T cell activation nor T cell expansion in vitro and in vivo as determined by MLR assays, phenotypic analysis of donor T cells with regard to expression of the CD25 activation antigen and calculation of donor CD4+ and CD8+ T cell numbers on days +3 and +6 post-BMT. Thus, SAHA treatment was not able to inhibit the strong upregulation of CD25 antigen on CD8+ T cells observed during induction of GVHD on days +3 and +6 post-BMT. We therefore focused on the effects of SAHA treatment on efferent immune effects including cytokine secretion and intracellular signaling events in vitro and in vivo following GVHD induction. SAHA treatment broadly inhibited lipopolysaccharide [LPS] and allo-antigen-induced cytokine/chemokine secretion in vitro like MIP-1-α, IP-10, IFN-γ, TNF-α and IL-6 and led also to a significant decrease in IFN-γ and TNF-α levels in vivo following induction of GVHD. Concomitantly, SAHA treatment inhibited phosphorylation of STAT1 and STAT3 in response to LPS and allo-activation in vitro. Furthermore, analysis of liver tissue and spleens from SAHA-treated animals with GVHD showed a significant decrease in phosphorylated STAT1. In contrast SAHA treatment had only moderate effects on p38 or ERK1,2 Mitogen-activated Protein Kinase (MAPK) pathway underscoring the relevance of the inhibition of the STAT1 pathway. In conclusion, GVHD is associated with a strong induction of phosphorylation of STAT1 in the liver and spleen and SAHA-dependent reduction of GVHD is associated with systemic and local inhibition of pSTAT1 and modulation of the inflammatory cytokine milieu during the efferent immune response.


Author(s):  
Eun-Mi Noh ◽  
Jeong-Mi Kim ◽  
Hak Yong Lee ◽  
Hyun-Kyung Song ◽  
Sang Ok Joung ◽  
...  

Abstract Background Platycodon grandiflorum is a flowering plant that is used in traditional medicine for treating pulmonary and respiratory disorders. It exerts various pharmacological effects, including immunomodulatory and anti-cancer activities. The purpose of this study was to confirm the in vitro and in vivo immune-enhancing effects of P. grandiflorum extract (PGE) on splenocytes isolated from cyclophosphamide (CP)-induced immunosuppressed rats. Methods For in vitro analysis, splenocytes were treated with PGE at various doses along with CP. Cell viability was measured by a WST-1 assay, and NK cell activity and cytotoxic T lymphocyte (CTL) activity was also examined. In addition, immunoglobulin A (IgA), IgG, and cytokine levels were measured. For in vivo analysis, Sprague Dawley rats were treated with various doses of PGE along with CP. Complete blood count (CBC) was performed, and plasma levels of IgA, IgG, TNF-α, IFN-γ, IL-2, and IL-12 were quantified. Additionally, tissue damage was assessed through histological analyses of the thymus and spleen. Results PGE treatment enhanced cell viability and natural killer cell and cytotoxic T lymphocyte activity, and increased the production of CP-induced inflammatory cytokines (TNF-α, IFN-γ, IL-2, and IL-12) and immunoglobulins (IgG and IgA) in splenocytes. In addition, in CP-treated rats, PGE treatment induced the recovery of white blood cell, neutrophil, and lymphocyte counts, along with mid-range absolute counts, and increased the serum levels of inflammatory cytokines (TNF-α, IFN-γ, IL-2, and IL-12) and immunoglobulins (IgG and IgA). Moreover, PGE attenuated CP-induced spleen and thymic damage. Conclusions Our results confirmed that PGE exerts an immune-enhancing effect both in vitro and in vivo, suggesting that PGE may have applications as a component of immunostimulatory agents or as an ingredient in functional foods.


2004 ◽  
Vol 72 (5) ◽  
pp. 2477-2483 ◽  
Author(s):  
Naoko Aoki ◽  
Anna Zganiacz ◽  
Peter Margetts ◽  
Zhou Xing

ABSTRACT DAP12 and its associating molecules MDL-1, TREM-1, and TREM-2 are the recently identified immune regulatory molecules, expressed primarily on myeloid cells including monocytes/macrophages, dendritic cells, NK cells, and neutrophils. However, little is known about the regulation of their expression during host antimicrobial responses. We have investigated the effect of pulmonary mycobacterial infection and type 1 cytokines on the expression of these molecules both in vivo and in vitro. While DAP12 was constitutively expressed at high levels in the lungs, the MDL-1, TREM-1, and TREM-2 molecules were inducible during mycobacterial infection. Their kinetic expression was correlated with that of the type 1 cytokines tumor necrosis factor alpha (TNF-α) and gamma interferon (IFN-γ). In primary lung macrophage cultures, high constitutive levels of DAP12 and TREM-2 were not modulated by mycobacterial or type 1 cytokine exposure. In contrast, expression of both MDL-1 and TREM-1 was markedly induced by mycobacterial infection and such induction was inhibited by concurrent exposure to IFN-γ. On mycobacterial infection of TNF-α−/− and IFN-γ−/− mice in vivo or their lung macrophages in vitro, TNF-α was found to be critical for mycobacterially induced MDL-1, but not TREM-1, expression whereas IFN-γ negatively regulated mycobacterially induced MDL-1 and TREM-1 expression. Our findings thus suggest that DAP12 and its associating molecules are differentially regulated by mycobacterial infection and type 1 cytokines and that MDL-1- and TREM-1-triggered DAP12 signaling may play an important role in antimicrobial type 1 immunity.


2012 ◽  
Vol 2012 ◽  
pp. 1-10 ◽  
Author(s):  
E. W. Baars ◽  
M. C. Jong ◽  
I. Boers ◽  
A. F. M. Nierop ◽  
H. F. J. Savelkoul

This paper examined the effects of the combined product,Citrus e fructibus/Cydonia e fructibus(Citrus/Cydonia; Citrus and Cydonia: each 0.01 g/mL), and separate products of Citrus (0.01 g/mL) and Cydonia (0.01 g/mL) on the immunological pathways involved in seasonal allergic rhinitis (SAR). Peripheral blood mononuclear cells (PBMCs) from five healthy and five grass pollen-allergic donors were isolated and analyzedin vitroafter polyclonal and allergen-specific stimulation of T cells in the presence of the three extracts. The analyses demonstrated acceptable cell survival with no signs of toxicity. Citrus mainly had a selective effect on reducing allergen-specific chronic inflammatory (TNF-α; Citrus compared to Cydonia and Citrus/Cydonia: −87.4 (P<0.001) and −68.0 (P<0.05), resp.) and Th2 pathway activity (IL-5; Citrus compared to Cydonia: −217.8 (P<0.01); while, both Cydonia and Citrus/Cydonia mainly affected the induction of the allergen-specific Th1 pathway (IFN-γ; Cydonia and Citrus/Cydonia compared to Citrus: 3.8 (P<0.01) and 3.0 (P<0.01), resp.). Citrus and Cydonia demonstrated different working mechanisms in the treatment of SAR and the combination product did not demonstrate larger effects than the separate preparations. Further effectiveness and efficacy studies comparing the effects of the products on SARin vivoare indicated.


2022 ◽  
Author(s):  
Zheng Zhihui ◽  
Yuqian Zhang ◽  
Gang Tian ◽  
Zehua Wang ◽  
Ronghua Wang ◽  
...  

Abstract Background Pudilan Xiaoyan Oral Liquid (PDL) as a famous Chinese patent medicine has been widely used for treating upper respiratory tract infection. However, the antiviral effect of PDL remain unclear. Here, the antiviral effect of in vitro and in vivo of PDL against influenza A virus were for the first time investigated. Methods The in vitro inhibitory effect of PDL on influenza A virus was investigated using MDCK cell model. The in vivo inhibitory effect on influenza virus pneumonia was evaluated with the ICR female mice (14-16 g) model infected by influenza A virus (A/FM/1/47, H1N1, mouse-adapted). Moreover, expression levels of inflammatory cytokines including TNF-α, IP10, IL-10, IL-1β, IL-6 and IFN-γ in lung tissue were measured by qRT-PCR. The potential mechanism of PDL against acute lung injury caused by influenza A virus was investigated by RT-PCR and Western blot. Results Our results indicated that in vitro PDL has a broad-spectrum inhibitory effect on different subtypes of influenza A viruses and in vivo PDL could dose-dependently prevent weight loss of mice, increase food intake and reduce mortality caused by influenza A H1N1 virus. Furthermore, PDL could markedly improve the acute lung injury caused by influenza A virus and significantly reduce the mRNA levels of inflammatory factors such as TNF-α, IP10, IL-10, IL-1β, IL-6, and IFN-γ. Mechanistic research indicated that the protective effect of PDL on viral pneumonia might be achieved by inhibiting TLR3/MyD88/IRAK4/TRAF3 signaling pathway. Conclusion PDL not only showed a good inhibitory effect on influenza A virus in vitro, but also exhibited a significant protective effect against lethal influenza virus infection in vivo. These findings provide evidence for the clinical treatment of influenza A virus infection with PDL.


2012 ◽  
Vol 2012 ◽  
pp. 1-10 ◽  
Author(s):  
Jin-Yi Han ◽  
Sun-Young Ahn ◽  
Eun-Hye Oh ◽  
Sang-Yoon Nam ◽  
Jin Tae Hong ◽  
...  

This study investigated the neuroprotective activity of red ginseng extract (RGE,Panax ginseng, C. A. Meyer) against kainic acid- (KA-) induced excitotoxicityin vitroandin vivo. In hippocampal cells, RGE inhibited KA-induced excitotoxicity in a dose-dependent manner as measured by the MTT assay. To study the possible mechanisms of the RGE-mediated neuroprotective effect against KA-induced cytotoxicity, we examined the levels of intracellular reactive oxygen species (ROS) and [Ca2+]iin cultured hippocampal neurons and found that RGE treatment dose-dependently inhibited intracellular ROS and [Ca2+]ielevation. Oral administration of RGE (30 and 200 mg/kg) in mice decreased the malondialdehyde (MDA) level induced by KA injection (30 mg/kg, i.p.). In addition, similar results were obtained after pretreatment with the radical scavengers Trolox andN,N′-dimethylthiourea (DMTU). Finally, after confirming the protective effect of RGE on hippocampal brain-derived neurotropic factor (BDNF) protein levels, we found that RGE is active compounds mixture in KA-induced hippocampal mossy-fiber function improvement. Furthermore, RGE eliminated 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals, and the IC50was approximately 10 mg/ml. The reductive activity of RGE, as measured by reaction with hydroxyl radical (•OH), was similar to trolox. The second-order rate constant of RGE for•OH was 3.5–4.5×109 M−1·S−1. Therefore, these results indicate that RGE possesses radical reduction activity and alleviates KA-induced excitotoxicity by quenching ROS in hippocampal neurons.


Sign in / Sign up

Export Citation Format

Share Document